Zobrazeno 1 - 10
of 106
pro vyhledávání: '"Temduang Limpaiboon"'
Autor:
Patthra Pason, Chakrit Tachaapaikoon, Waralee Suyama, Rattiya Waeonukul, Rong Shao, Molin Wongwattanakul, Temduang Limpaiboon, Chirapond Chonanant, Nipaporn Ngernyuang
Publikováno v:
Toxicology Reports, Vol 12, Iss , Pp 82-90 (2024)
Colorectal carcinoma (CRC) is one of the most common malignancies, though there are no effective therapeutic regimens at present. This study aimed to investigate the inhibitory effects of mannooligosaccharides extracted from coconut meal (CMOSs) on t
Externí odkaz:
https://doaj.org/article/0019e2e1c2164ec8b7bd6754597f83a9
Autor:
Nipaporn Ngernyuang, Molin Wongwattanakul, Wannit Charusirisawad, Rong Shao, Temduang Limpaiboon
Publikováno v:
Heliyon, Vol 8, Iss 12, Pp e12028- (2022)
Cholangiocarcinoma (CCA) is a rare malignancy of the biliary tract with extremely poor clinical outcomes due to a lack of effective therapies to improve disease management. The emerging green synthesis of gold nanoparticles (AuNPs) has extensively pr
Externí odkaz:
https://doaj.org/article/4822b53e180c4323a94df673ecf57eca
Autor:
David K. Lau, Dmitri Mouradov, Wiphawan Wasenang, Ian Y. Luk, Cameron M. Scott, David S. Williams, Yvonne H. Yeung, Temduang Limpaiboon, George F. Iatropoulos, Laura J. Jenkins, Camilla M. Reehorst, Fiona Chionh, Mehrdad Nikfarjam, Daniel Croagh, Amardeep S. Dhillon, Andrew J. Weickhardt, Toshihide Muramatsu, Yoshimasa Saito, Niall C. Tebbutt, Oliver M. Sieber, John M. Mariadason
Publikováno v:
iScience, Vol 21, Iss , Pp 624-637 (2019)
Summary: Biliary tract cancers (BTCs) currently have no approved targeted therapies. Although genomic profiling of primary BTCs has identified multiple potential drug targets, accurate models are needed for their evaluation. Genomic profiling of 22 B
Externí odkaz:
https://doaj.org/article/60855650f6624ff1817442e9b3685ec7
Autor:
Son Dinh An Truong, Molin Wongwattanakul, Tanakorn Proungvitaya, Temduang Limpaiboon, Sittiruk Roytrakul, Daraporn Chua-on, Doungdean Tummanatsakun, Siriporn Proungvitaya
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 13, p 3826 (2022)
Cholangiocarcinoma (CCA), a malignancy of the biliary epithelium, can arise at any point in the biliary system. We previously reported that CIAPIN1 is detectable in the sera and that its overexpression was associated with poor prognosis and metastasi
Externí odkaz:
https://doaj.org/article/a25b4b0a5fc04b09b947797adbb9afd2
Publikováno v:
Clinical Epigenetics, Vol 11, Iss 1, Pp 1-10 (2019)
Abstract Background Cholangiocarcinoma (CCA) is a fatal cancer of the bile duct epithelial cell lining. The misdiagnosis of CCA and other biliary diseases may occur due to the similarity of clinical manifestations and blood tests resulting in inappro
Externí odkaz:
https://doaj.org/article/703ca35ecc2340ff86f5e84b82d2af73
Autor:
Mang Ngaih Ciin, Tanakorn Proungvitaya, Temduang Limpaiboon, Ubon Cha’on, Sittiruk Roytrakul, Siriporn Proungvitaya
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 14, Iss 3 (2020)
Background: Cholangiocarcinoma (CCA) is the second most common primary hepatobiliary cancer. These patients have meager prognosis and short-term survival. Precise assessment of glomerular filtration rate is a fundamental aspect of clinical care in ca
Externí odkaz:
https://doaj.org/article/a7699ea98de54a96b7532272c6ec9b2b
Autor:
Son Dinh An Truong, Doungdean Tummanatsakun, Tanakorn Proungvitaya, Temduang Limpaiboon, Molin Wongwattanakul, Daraporn Chua-on, Sittiruk Roytrakul, Siriporn Proungvitaya
Publikováno v:
Diagnostics, Vol 11, Iss 6, p 1054 (2021)
The mortality rate of cholangiocarcinoma (CCA) is high since there is a lack of a non-invasive technique to accurately detect tumors at the early stage. CCA biomarkers are consistently needed for various purposes including screening, early diagnosis,
Externí odkaz:
https://doaj.org/article/4e1079c73a2d4c7b9466c66d7bce77cb
Autor:
Daraporn Chua-on, Tanakorn Proungvitaya, Doungdean Tummanatsakun, Anchalee Techasen, Temduang Limpaiboon, Sittiruk Roytrakul, Sopit Wongkham, Chaisiri Wongkham, Ongart Somintara, Sakkarn Sangkhamanon, Siriporn Proungvitaya
Publikováno v:
Biomolecules, Vol 10, Iss 7, p 1021 (2020)
Prognosis of cholangiocarcinoma (CCA) patients is absolutely poor. Since improvement of prognosis and/or response to treatment by personalized and precision treatments requires earlier and precise diagnostic markers, discovery of prognostic markers a
Externí odkaz:
https://doaj.org/article/d2fb0662bdfa4c9abdf99ccf6297ebea
Autor:
Doungdean Tummanatsakun, Tanakorn Proungvitaya, Sittiruk Roytrakul, Temduang Limpaiboon, Sopit Wongkham, Chaisiri Wongkham, Atit Silsirivanit, Ongart Somintara, Sakkarn Sangkhamanon, Siriporn Proungvitaya
Publikováno v:
Biomolecules, Vol 9, Iss 9, p 413 (2019)
Diagnostic and/or prognostic biomarkers for cholangiocarcinoma (CCA) are still insufficient with poor prognosis of patients. To discover a new CCA biomarker, we constructed our secretome database of three CCA cell lines and one control cholangiocyte
Externí odkaz:
https://doaj.org/article/8a94c36789c441c188baf68dbb9875e4
Autor:
Robert Brown, Temduang Limpaiboon, Andrew J. Walley, Afshan Siddiq, Wei Dai, Constanze Zeller, Ruethairat Sriraksa
PDF file - 57K, Histopathological features of CCA and matched adjacent normal samples.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1275973e0c9f24a1466751ade21af70f
https://doi.org/10.1158/1940-6207.22525745.v1
https://doi.org/10.1158/1940-6207.22525745.v1